Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Marnitz S, Köhler C, Rauer A, Schneider A, Budach V, Tsunoda A, Mangler M.

Strahlenther Onkol. 2014 Jan;190(1):34-40. doi: 10.1007/s00066-013-0403-5. Epub 2013 Jul 27.

PMID:
23887709
2.

Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.

Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):351-8.

PMID:
10030261
3.

Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.

Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.

Strahlenther Onkol. 2002 Jul;178(7):378-85.

PMID:
12163992
4.

Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.

Ramella S, Maranzano E, Frata P, Mantovani C, Lazzari G, Menichelli C, Navarria P, Pergolizzi S, Salvi F.

Tumori. 2012 Jan-Feb;98(1):66-78. doi: 10.1700/1053.11502.

PMID:
22495704
5.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
6.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.

Gynecol Oncol. 2005 Jan;96(1):168-72.

PMID:
15589596
7.

Practice patterns for oropharyngeal cancer in radiation oncology centers of Turkey.

Karakoyun-Celik O, Altun M, Olmezoglu A, Büyükpolat MY, Ozkök S, Akmansu M, Cengiz M, Onal C, Dizman A, Esassolak M.

Tumori. 2014 May-Jun;100(3):284-8. doi: 10.1700/1578.17204.

PMID:
25076239
8.

Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.

Kim YJ, Kim JY, Kim Y, Lim YK, Jeong J, Jeong C, Kim M, Lim MC, Seo SS, Park SY.

Strahlenther Onkol. 2016 Dec;192(12):922-930. Epub 2016 Oct 12.

PMID:
27734106
9.

Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Mangler M, Zech N, Schneider A, Köhler C, Marnitz S.

Geburtshilfe Frauenheilkd. 2013 Mar;73(3):227-238.

10.

Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.

Viswanathan AN, Erickson BA.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):104-9. doi: 10.1016/j.ijrobp.2009.01.043.

PMID:
19619956
11.

Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK.

Jones B, Tan LT, Blake PR, Dale RG.

Br J Radiol. 1994 Dec;67(804):1226-30.

PMID:
7874422
12.

Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.

Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):243-53. doi: 10.1016/j.ijrobp.2015.10.027. Epub 2015 Oct 20.

PMID:
26853333
13.

Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey.

Macchia G, Sainato A, Talamini R, Boz G, Bacigalupo A, Caravatta L, Fiore M, Friso ML, Fusco V, Lupattelli M, Mantello G, Mattiucci GC, Slim N, Sciacero P, Turri L, Valentini V, Morganti AG, Genovesi D.

Oncol Rep. 2015 Jul;34(1):382-90. doi: 10.3892/or.2015.3955. Epub 2015 May 6.

PMID:
25955190
14.

International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG).

Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, Reed N, Long H, Kim HJ, Marth C, Lindegaard JC, Cerrotta A, Small W Jr, Trimble E.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):250-5. doi: 10.1016/j.ijrobp.2010.10.030. Epub 2010 Dec 22.

15.

Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.

Castelnau-Marchand P, Chargari C, Maroun P, Dumas I, Del Campo ER, Cao K, Petit C, Martinetti F, Tafo-Guemnie A, Lefkopoulos D, Morice P, Haie-Meder C, Mazeron R.

Gynecol Oncol. 2015 Nov;139(2):288-94. doi: 10.1016/j.ygyno.2015.09.008. Epub 2015 Sep 11.

PMID:
26364808
16.

Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.

Clivio A, Kluge A, Cozzi L, Köhler C, Neumann O, Vanetti E, Wlodarczyk W, Marnitz S.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):897-903. doi: 10.1016/j.ijrobp.2013.08.027. Epub 2013 Oct 9.

PMID:
24119834
17.

Treatment of T3 laryngeal cancer in the Netherlands: a national survey.

Doornaert P, Terhaard CH, Kaanders JH; Dutch National Platform Radiotherapy Head and Neck Cancer.

Radiat Oncol. 2015 Jun 26;10:134. doi: 10.1186/s13014-015-0440-6.

18.

The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.

Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ.

Radiother Oncol. 2003 Apr;67(1):69-76.

PMID:
12758242
19.

[Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Ganansia V, Bernard A, Antoine JM, Jannet D, Lhuillier PE, Uzan M, Genestie C, Antoine M, Jamali M, Milliez J, Uzan S, Blondon J.

Cancer Radiother. 2002 Jun;6(4):217-37. French.

PMID:
12224488
20.

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan.

Ikeda Y, Furusawa A, Kitagawa R, Tokinaga A, Ito F, Ukita M, Nomura H, Yamagami W, Tanabe H, Mikami M, Takeshima N, Yaegashi N.

J Gynecol Oncol. 2016 May;27(3):e29. doi: 10.3802/jgo.2016.27.e29.

Supplemental Content

Support Center